Publications by authors named "Rob van der Pas"

Claim this Profile
A
A Prospective Trial With Ketoconazole Induction Therapy and Octreotide Maintenance Treatment for Cushing's Disease.
Ticiana Paes, Rob van der Pas, Peter M van Koetsveld, Fadime Dogan, Kees K A van den Berge

J Endocr Soc· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-arrestin expression in corticotroph tumor cells is modulated by glucocorticoids.
Federico Gatto, Richard A Feelders, Rob van der Pas, Peter van Koetsveld, Eleonora Bruzzone

J Endocrinol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.
Federico Gatto, Richard Feelders, Rob van der Pas, Johan M Kros, Fadime Dogan

Endocrinology· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent developments in drug therapy for Cushing's disease.
Rob van der Pas, Wouter W de Herder, Leo J Hofland, Richard A Feelders

Drugs· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly.
Federico Gatto, Richard A Feelders, Rob van der Pas, Johan M Kros, Marlijn Waaijers

J Clin Endocrinol Metab· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis